chartexchange

Polyrizon Announces Successful Completion Enrollment of all 120 Patients in U.S. Clinical Study of NASARIX Allergy Blocker

GlobeNewswire Inc. | Oct 27, 2026 8:16 AM EDT

All 120 planned participants randomized across five clinical sites in the United States

Read original article